[Bone protection in corticosteroid treated patients].

Area of Science:

• Nephrology
• Endocrinology
• Bone Metabolism

Background:

• Corticosteroid therapy is associated with an increased risk of fractures.
• Effective bone protection strategies are crucial for patients on long-term corticosteroid treatment.
• Variability in clinical practice may lead to suboptimal bone health management.

Purpose of the Study:

• To evaluate the current practices for bone protection in patients receiving corticosteroid therapy across nephrology centers in Piedmont and Aosta Valley.
• To identify variations in fracture risk assessment and therapeutic interventions.
• To highlight areas for potential improvement in clinical management guidelines.

Main Methods:

• A comparative analysis of 15 nephrology centers in Piedmont and Aosta Valley.
• Data collection on fracture prevalence, risk factor assessment (including sex, age, menopausal status, fracture history, smoking, alcohol, glucocorticoid dose/duration, bone age, calcium/phosphorus status), and bone mineral density testing (Dual-energy X-ray absorptiometry - DXA).
• Review of pharmacological interventions, including Vitamin D, calcium carbonate, and bisphosphonates.

Main Results:

• Significant variability in fracture prevalence was observed across centers, ranging from 0% to 18%.
• Inconsistent application of fracture risk assessment tools, with only one center utilizing FRAX (Fracture Risk Assessment Tool).
• Heterogeneous approaches to bone mineral density assessment and pharmacological management, including Vitamin D, calcium, and bisphosphonate use.

Conclusions:

• There is substantial variability in the clinical and therapeutic management of bone protection for patients on corticosteroid therapy in the studied regions.
• Standardization of risk assessment and treatment protocols is needed to ensure optimal bone health outcomes.
• Further research and guideline implementation are recommended to address the observed discrepancies in care.